South Korea to start talks on COVID-19 drug remdesivir purchases

South Korea said it will begin talks with Gilead Sciences to purchase stocks of remdesivir, one of the first drugs shown to be effective against COVID-19, after the company agreed to allocate nearly all of its supply to the U.S. over the next three months.

Subscribe:

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:

reuters,business,finance,news,politics,top news,headlines,breaking news,news today,bloomberg,thomson reuters,coronavirus,coronavirus news,coronavirus update,コロナウイルス,usa coronavirus,coronavirus deaths,el coronavirus,corona,coronavirus cases,remdesivir,Gilead Sciences,South Korea,